mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.8 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.8 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.8 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |